News & Media

Press Releases

Oct 17, 2017
Amedica Receives Positive Nasdaq Listing Decision

SALT LAKE CITY, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical applications, announced today that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for an extension within which to evidence full compliance with the criteria for continued listing on The Nasdaq Capital Market, including the filing requirement and the $1.00 closing bid price requirement. The Company’s continued listing on Nasdaq is subject to the Company filing…

View All News

Events Calendar

Oct 25–October 28, 2017
NASS 2017 Annual Meeting

Orlando, FL

View All Events

Tweets